Respiratory ATP synthesis: the new generation of mycobacterial drug targets?
Open Access
- 20 March 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 308 (1), 1-7
- https://doi.org/10.1111/j.1574-6968.2010.01959.x
Abstract
Mycobacterium tuberculosis, the causative agent of tuberculosis, poses a global health challenge due to the emergence of drug-resistant strains. Recently, bacterial energy metabolism has come into focus as a promising new target pathway for the development of antimycobacterial drugs. This review summarizes our current knowledge on mycobacterial respiratory energy conversion, in particular, during the physiologically dormant state that is associated with latent or persistent tuberculosis infections. Targeting components of respiratory ATP production, such as type-2 NADH dehydrogenase or ATP synthase, is illustrated as an emerging strategy in the development of novel drugs.Keywords
This publication has 43 references indexed in Scilit:
- Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viabilityMicrobiology, 2009
- Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic HomologueAntimicrobial Agents and Chemotherapy, 2009
- Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosisNature Reviews Microbiology, 2009
- The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Synergistic Activity of R207910 Combined with Pyrazinamide against Murine TuberculosisAntimicrobial Agents and Chemotherapy, 2007
- Combinations of R207910 with Drugs Used To Treat Multidrug-Resistant Tuberculosis Have the Potential To Shorten Treatment DurationAntimicrobial Agents and Chemotherapy, 2006
- In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulceransAntimicrobial Agents and Chemotherapy, 2006
- Function of the Cytochrome bc 1 - aa 3 Branch of the Respiratory Network in Mycobacteria and Network Adaptation Occurring in Response to Its DisruptionJournal of Bacteriology, 2005
- Functional properties of the alternative NADH:ubiquinone oxidoreductase from E. coli through comparative 3‐D modellingFEBS Letters, 2004
- Massive gene decay in the leprosy bacillusNature, 2001